SLVRX
Price
$35.50
Change
+$0.23 (+0.65%)
Updated
Jul 3 closing price
Net Assets
2.42B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

SLVRX vs VVIAX

Header iconSLVRX vs VVIAX Comparison
Open Charts SLVRX vs VVIAXBanner chart's image
Columbia Select Large Cap Value R
Price$35.50
Change+$0.23 (+0.65%)
VolumeN/A
Net Assets2.42B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
SLVRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SLVRX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLVRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. SLVRX (2.42B). VVIAX pays higher dividends than SLVRX: VVIAX (2.18) vs SLVRX (1.38). SLVRX was incepted earlier than VVIAX: SLVRX (22 years) vs VVIAX (25 years). SLVRX (1.33) is less costly to investors than VVIAX (0.05). SLVRX is a more actively managed with annual turnover of: 20.00 vs. VVIAX (9.00). SLVRX has a lower initial minimum investment than VVIAX: SLVRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. SLVRX (11.21). VVIAX return over 5 years is better than : 80.13 vs. SLVRX (74.06).
SLVRXVVIAXSLVRX / VVIAX
Total Expense Ratio1.050.052,100%
Annual Report Gross Expense Ratio1.330.052,660%
Fund Existence22 years25 years-
Gain YTD9.9076.198160%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.42B189B1%
Annual Yield % from dividends1.382.1863%
Returns for 1 year11.2112.0393%
Returns for 3 years37.2035.17106%
Returns for 5 years74.0680.1392%
Returns for 10 years70.84115.6761%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.